Predictors of coronary stent thrombosis

Revision as of 20:32, 17 December 2009 by Smitakohli (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for Predictors of coronary stent thrombosis

Articles

Most recent articles on Predictors of coronary stent thrombosis

Most cited articles on Predictors of coronary stent thrombosis

Review articles on Predictors of coronary stent thrombosis

Articles on Predictors of coronary stent thrombosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Predictors of coronary stent thrombosis

Images of Predictors of coronary stent thrombosis

Photos of Predictors of coronary stent thrombosis

Podcasts & MP3s on Predictors of coronary stent thrombosis

Videos on Predictors of coronary stent thrombosis

Evidence Based Medicine

Cochrane Collaboration on Predictors of coronary stent thrombosis

Bandolier on Predictors of coronary stent thrombosis

TRIP on Predictors of coronary stent thrombosis

Clinical Trials

Ongoing Trials on Predictors of coronary stent thrombosis at Clinical Trials.gov

Trial results on Predictors of coronary stent thrombosis

Clinical Trials on Predictors of coronary stent thrombosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Predictors of coronary stent thrombosis

NICE Guidance on Predictors of coronary stent thrombosis

NHS PRODIGY Guidance

FDA on Predictors of coronary stent thrombosis

CDC on Predictors of coronary stent thrombosis

Books

Books on Predictors of coronary stent thrombosis

News

Predictors of coronary stent thrombosis in the news

Be alerted to news on Predictors of coronary stent thrombosis

News trends on Predictors of coronary stent thrombosis

Commentary

Blogs on Predictors of coronary stent thrombosis

Definitions

Definitions of Predictors of coronary stent thrombosis

Patient Resources / Community

Patient resources on Predictors of coronary stent thrombosis

Discussion groups on Predictors of coronary stent thrombosis

Patient Handouts on Predictors of coronary stent thrombosis

Directions to Hospitals Treating Predictors of coronary stent thrombosis

Risk calculators and risk factors for Predictors of coronary stent thrombosis

Healthcare Provider Resources

Symptoms of Predictors of coronary stent thrombosis

Causes & Risk Factors for Predictors of coronary stent thrombosis

Diagnostic studies for Predictors of coronary stent thrombosis

Treatment of Predictors of coronary stent thrombosis

Continuing Medical Education (CME)

CME Programs on Predictors of coronary stent thrombosis

International

Predictors of coronary stent thrombosis en Espanol

Predictors of coronary stent thrombosis en Francais

Business

Predictors of coronary stent thrombosis in the Marketplace

Patents on Predictors of coronary stent thrombosis

Experimental / Informatics

List of terms related to Predictors of coronary stent thrombosis

Cardiology Network

Discuss Predictors of coronary stent thrombosis further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-in-Chief: Smita Kohli, M.D.

Overview

A number of clinical, angiographic, and procedural factors predispose to the occurrence of stent thrombosis. Predictors of stent thrombosis can be classified into anatomic variables, procedure related variables and clinical variables. A new entity which has been recently recognised and is being increasingly studied in relation to stent thrombosis is hyporesponsiveness to antiplatelet agents.


Procedure related variables: Procedure related variables include stent underexpansion, margin dissections, incomplete wall apposition, residual inflow and outflow disease, overlapping stent, polymer materials and use of self expanding or coil stents[1].

Anatomic variables: Lesion-specific factors that increase the likelihood of stent thrombosis include a residual dissection at the margin of the stent, impaired flow into or out of the stent, small stent diameters (<3 mm), long stent lengths, and treatment of an acute myocardial infarction[1].

Clinical variables: Clinical variables include acute myocardial infarction, clopidogrel noncompliance and discontinuation, hyporesponsiveness to antiplatelet agents, higher baseline platelet count, diabetes mellitus, renal failure, congestive heart failure, prior radiation brachytherapy[1][2].


In addition to these, stent implantation for off-label indication of both DES and BMS(such as restenotic lesions, bypass graft lesions, left main coronary artery disease, as well as ostial, bifurcated, and totally occluded lesions) has been associated with higher rates of ischemic complications, including stent thrombosis, as compared with standard indications[3][4]. In a case control study of 145 patients with stent thrombosis by Rinaldi et al[1], presence of angiographic thrombus prior to stenting, greater total stent length, higher baseline platelet count, acute MI indication, the use of a self expanding or coil stent, and GpIIb-IIIa exposure were identified as the strongest predictors of stent thrombosis.

In another study by Marroquin et al[5] to compare the outcomes in bare-metal versus drug-elting stents for off-label indications showed that one year after intervention, there were no significant differences in the adjusted risk of death or myocardial infarction in patients with drug-eluting stents as compared with those with bare-metal stents. These findings implicate that the poorer outcome observed after stenting for off-label indications are related to patient and lesion characteristics but not to the stent itself. Therefore, large randomized clinical trial are needed to further study the use of DES for off label versus standard indications.

References

  1. 1.0 1.1 1.2 1.3 Rinaldi MJ, Kirtane AJ, Piana RN; et al. (2008). "Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events". Am. Heart J. 155 (4): 654–60. doi:10.1016/j.ahj.2007.11.028. PMID 18371472. Unknown parameter |month= ignored (help)
  2. Iakovou I, Schmidt T, Bonizzoni E; et al. (2005). "Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents". JAMA. 293 (17): 2126–30. doi:10.1001/jama.293.17.2126. PMID 15870416. Unknown parameter |month= ignored (help)
  3. Beohar N, Davidson CJ, Kip KE; et al. (2007). "Outcomes and complications associated with off-label and untested use of drug-eluting stents". JAMA. 297 (18): 1992–2000. doi:10.1001/jama.297.18.1992. PMID 17488964. Unknown parameter |month= ignored (help)
  4. Win HK, Caldera AE, Maresh K; et al. (2007). "Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents". JAMA. 297 (18): 2001–9. doi:10.1001/jama.297.18.2001. PMID 17488965. Unknown parameter |month= ignored (help)
  5. Marroquin OC, Selzer F, Mulukutla SR; et al. (2008). "A comparison of bare-metal and drug-eluting stents for off-label indications". N. Engl. J. Med. 358 (4): 342–52. doi:10.1056/NEJMoa0706258. PMC 2761092. PMID 18216354. Unknown parameter |month= ignored (help)